Literature DB >> 12435672

A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes.

Eleonora Giovanetti1, Andrea Brenciani, Roberto Burioni, Pietro Emanuele Varaldo.   

Abstract

Streptococcus pyogenes strains inducibly resistant (iMLS phenotype) to macrolide, lincosamide, and streptogramin B (MLS) antibiotics can be subdivided into three phenotypes: iMLS-A, iMLS-B, and iMLS-C. This study focused on inducibly erythromycin-resistant S. pyogenes strains of the iMLS-B and iMLS-C types, which are very similar and virtually indistinguishable in a number of phenotypic and genotypic features but differ clearly in their degree of resistance to MLS antibiotics (high in the iMLS-B type and low in the iMLS-C type). As expected, the iMLS-B and iMLS-C test strains had the erm(A) methylase gene; the iMLS-A and the constitutively resistant (cMLS) isolates had the erm(B) methylase gene; and a control M isolate had the mef(A) efflux gene. mre(A) and msr(A), i.e., other macrolide efflux genes described in gram-positive cocci, were not detected in any test strain. With a radiolabeled erythromycin method for determination of the intracellular accumulation of the drug in the absence or presence of an efflux pump inhibitor, active efflux of erythromycin was observed in the iMLS-B isolates as well as in the M isolate, whereas no efflux was demonstrated in the iMLS-C isolates. By the triple-disk (erythromycin plus clindamycin and josamycin) test, performed both in normal test medium and in the same medium supplemented with the efflux pump inhibitor, under the latter conditions iMLS-B and iMLS-C strains were no longer distinguishable, all exhibiting an iMLS-C phenotype. In conjugation experiments with an iMLS-B isolate as the donor and a Rif(r) Fus(r) derivative of an iMLS-C isolate as the recipient, transconjugants which shared the iMLS-B type of the donor under all respects, including the presence of an efflux pump, were obtained. These results indicate the existence of a novel, transferable efflux system, not associated with mef(A) or with other known macrolide efflux genes, that is peculiar to iMLS-B strains. Whereas the low-level resistance of iMLS-C strains to MLS antibiotics is apparently due to erm(A)-encoded methylase activity, the high-level resistance of iMLS-B strains appears to depend on the same methylase activity plus the new efflux system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435672      PMCID: PMC132784          DOI: 10.1128/AAC.46.12.3750-3755.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  The role of efflux in macrolide resistance.

Authors:  Ping Zhong; Virginia D. Shortridge
Journal:  Drug Resist Updat       Date:  2000-12       Impact factor: 18.500

2.  Outbreak of group A streptococci in a burn center: use of pheno- and genotypic procedures for strain tracking.

Authors:  P Gruteke; A van Belkum; L M Schouls; W D Hendriks; F A Reubsaet; J Dokter; H Boxma; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 3.  Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.

Authors:  Roland Leclercq
Journal:  Clin Infect Dis       Date:  2002-01-11       Impact factor: 9.079

4.  Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.

Authors:  A Tait-Kamradt; T Davies; M Cronan; M R Jacobs; P C Appelbaum; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

5.  Emergence of group A streptococcus strains with different mechanisms of macrolide resistance.

Authors:  Edouard Bingen; Roland Leclercq; Frédéric Fitoussi; Naïma Brahimi; Brigitte Malbruny; Dominique Deforche; Robert Cohen
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

6.  Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes.

Authors:  J Clancy; J Petitpas; F Dib-Hajj; W Yuan; M Cronan; A V Kamath; J Bergeron; J A Retsema
Journal:  Mol Microbiol       Date:  1996-12       Impact factor: 3.501

7.  Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America.

Authors:  A Tait-Kamradt; T Davies; P C Appelbaum; F Depardieu; P Courvalin; J Petitpas; L Wondrack; A Walker; M R Jacobs; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

8.  Conjugative transfer of the erm(A) gene from erythromycin-resistant Streptococcus pyogenes to macrolide-susceptible S. pyogenes, Enterococcus faecalis and Listeria innocua.

Authors:  E Giovanetti; G Magi; A Brenciani; C Spinaci; R Lupidi; B Facinelli; P E Varaldo
Journal:  J Antimicrob Chemother       Date:  2002-08       Impact factor: 5.790

9.  Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides.

Authors:  L Wondrack; M Massa; B V Yang; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

View more
  14 in total

1.  Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae.

Authors:  Maria P Montanari; Ileana Cochetti; Marina Mingoia; Pietro E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

Review 2.  Genetic elements responsible for erythromycin resistance in streptococci.

Authors:  Pietro E Varaldo; Maria Pia Montanari; Eleonora Giovanetti
Journal:  Antimicrob Agents Chemother       Date:  2008-11-10       Impact factor: 5.191

3.  Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants.

Authors:  P Littauer; D A Caugant; M Sangvik; E A Høiby; A Sundsfjord; G S Simonsen
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

4.  New genetic element carrying the erythromycin resistance determinant erm(TR) in Streptococcus pneumoniae.

Authors:  Romina Camilli; Maria Del Grosso; Francesco Iannelli; Annalisa Pantosti
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

5.  Genetic diversity of cell-invasive erythromycin-resistant and -susceptible group A streptococci determined by analysis of the RD2 region of the prtF1 gene.

Authors:  Cinzia Spinaci; Gloria Magi; Claudia Zampaloni; Luca A Vitali; Claudia Paoletti; Maria R Catania; Manuela Prenna; Luigi Ferrante; Sandro Ripa; Pietro E Varaldo; Bruna Facinelli
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

6.  Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Chun-Ming Lee; Wen-Kuei Huang; Tsu-Lan Wu; Jen-Hsien Wan; Dine Yang; Jainn-Ming Shyr; Yin-Ching Chuang; Jing-Jou Yan; Jang-Jih Lu; Jiunn-Jong Wu; Wen-Chien Ko; Feng-Yee Chang; Yi-Chueh Yang; Yeu-Jun Lau; Yung-Ching Liu; Hsieh-Shong Leu; Cheng-Yi Liu; Kwen-Tay Luh
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

7.  Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany.

Authors:  Ralf René Reinert; Angela Wild; Peter Appelbaum; Rudolf Lütticken; Murat Yücel Cil; Adnan Al-Lahham
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

8.  Genetic variability among ampC genes from acinetobacter genomic species 3.

Authors:  Alejandro Beceiro; Astrid Pérez; Felipe Fernández-Cuenca; Luis Martínez-Martínez; Alvaro Pascual; Jordi Vila; Jesús Rodríguez-Baño; Jose Miguel Cisneros; Jerónimo Pachón; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

9.  Antimicrobial activity of essential oils and carvacrol, and synergy of carvacrol and erythromycin, against clinical, erythromycin-resistant Group A Streptococci.

Authors:  Gloria Magi; Emanuela Marini; Bruna Facinelli
Journal:  Front Microbiol       Date:  2015-03-03       Impact factor: 5.640

10.  Mutation at the position 2058 of the 23S rRNA as a cause of macrolide resistance in Streptococcus pyogenes.

Authors:  Jari Jalava; Martti Vaara; Pentti Huovinen
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-05-06       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.